| Field | Row 1 |
|---|---|
| adsh | 0001829126-25-004454 |
| cik | 2033122 |
| name | BERTO ACQUISITION CORP. |
| sic | 6770 |
| countryba | US |
| stprba | NV |
| cityba | LAS VEGAS |
| zipba | 89144 |
| bas1 | 1180 NORTH TOWN CENTER DRIVE |
| bas2 | SUITE 100 |
| baph | 702-781-4313 |
| countryma | US |
| stprma | NV |
| cityma | LAS VEGAS |
| zipma | 89144 |
| mas1 | 1180 NORTH TOWN CENTER DRIVE |
| mas2 | SUITE 100 |
| countryinc | KY |
| stprinc | |
| ein | 994250815 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250612 |
| accepted | 2025-06-12 17:11:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | bertoacquisition_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-004454 | 20250331 | Note Payable Related Party | 189202.0000 | USD | 0 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Shares Outstanding | 7503750.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Shares; | ||
| 0001829126-25-004454 | 20250331 | Stockholders Equity | -581218.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Liabilities | 997334.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Accounts Payable Current | 563291.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 11023.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Common Stock Shares Authorized | 550000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Liabilities And Stockholders Equity | 578528.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Liabilities Current | 997334.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Other Accrued Liabilities Current | 400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-004454 | 20250331 | Profit Loss | -17928.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Stockholders Equity | 750.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Shares; | ||
| 0001829126-25-004454 | 20250331 | Stockholders Equity | -756218.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-004454 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 34044.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Common Stock Shares Issued | 7503750.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Increase Decrease In Accounts Payable | -6127.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Liabilities | 1159746.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-004454 | 20250331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-004454 | 20241231 | Additional Paid In Capital | 174250.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Assets Current | 11023.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Basic And Diluted Net Loss Per Ordinary Share | 0.0000 | USD | 1 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20241231 | Cash | 34044.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Deferred Offering Costs Associated With Proposed Public Offering | 400000.0000 | USD | 0 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20241231 | Liabilities And Stockholders Equity | 434044.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Stockholders Equity | -738290.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-004454 | 20250331 | Additional Paid In Capital | 174250.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Cash | 11023.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -23021.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Common Stock Shares Issued | 7503750.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Common Stock Value | 750.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Common Stock Value | 750.0000 | USD | 0 | us-gaap/2024 | This number includes up to 978,750 ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. | On April 29, 2025, the Company capitalized US$31.63 standing to the credit of the Companys share premium account and issued an additional 316,250 founder shares, resulting in an increase in the total number of ordinary shares outstanding from 7,187,500 to 7,503,750. All shares and associated amounts have been retroactively restated to reflect the | ||
| 0001829126-25-004454 | 20250331 | Deferred Offering Costs Included In Accounts Payable | 13380.0000 | USD | 1 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20250331 | General And Administrative Expenses Paid By Sponsor Under Promissory Note | 1034.0000 | USD | 1 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20250331 | Liabilities Current | 1159746.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Net Cash Provided By Used In Operating Activities | -23021.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Net Income Loss | -17928.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Retained Earnings Accumulated Deficit | -756218.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Stockholders Equity | -563290.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Assets | 434044.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Assets | 578528.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Common Stock Shares Authorized | 550000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Common Stock Shares Outstanding | 7503750.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Weighted Average Ordinary Shares Outstanding Basic And Diluted12 | 6525000.0000 | shares | 1 | 0001829126-25-004454 | On April 29, 2025, the Company capitalized US$31.63 standing to the credit of the Companys share premium account and issued an additional 316,250 founder shares, resulting in an increase in the total number of ordinary shares outstanding from 7,187,500 to 7,503,750. All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 5). | This number excludes an aggregate of up to 978,750 ordinary shares subject to forfeiture if the over-allotment option was not | ||
| 0001829126-25-004454 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Deferred Offering Costs Associated With Proposed Public Offering | 567505.0000 | USD | 0 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20241231 | Note Payable Related Party | 34043.0000 | USD | 0 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20241231 | Other Accrued Liabilities Current | 400000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Ordinary Shares; | |||
| 0001829126-25-004454 | 20241231 | Retained Earnings Accumulated Deficit | -738290.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Stockholders Equity | 174250.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-004454 | 20241231 | Stockholders Equity | 750.0000 | USD | 0 | us-gaap/2024 | Equity Components= Ordinary Shares; | On April 29, 2025, the Company capitalized US$31.63 standing to the credit of the Companys share premium account and issued an additional 316,250 founder shares, resulting in an increase in the total number of ordinary shares outstanding from 7,187,500 to 7,503,750. All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 5). | This number includes up to 978,750 ordinary shares subject to forfeiture if the over-allotment option was not exercised in fu | |
| 0001829126-25-004454 | 20250331 | Accounts Payable Current | 570544.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Assets Current | 34044.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Common Stock Shares Outstanding | 7503750.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Deferred Offering Costs Paid By Related Party Under Promissory Note | 154125.0000 | USD | 1 | 0001829126-25-004454 | |||
| 0001829126-25-004454 | 20250331 | General And Administrative Expense | 17928.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-004454 | 20250331 | Profit Loss | -17928.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-004454 | 20241231 | Shares Outstanding | 7503750.0000 | shares | 0 | us-gaap/2024 | Equity Components= Ordinary Shares; | ||
| 0001829126-25-004454 | 20250331 | Stockholders Equity | 174250.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Basic And Diluted Net Loss Per Ordinary Share | 0001829126-25-004454 | 1 | 0 | perShare | D | Basic and diluted net loss per ordinary share | ||
| Deferred Offering Costs Associated With Proposed Public Offering | 0001829126-25-004454 | 1 | 0 | monetary | I | D | Deferred offering costs associated with proposed public offering | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Note Payable Related Party | 0001829126-25-004454 | 1 | 0 | monetary | I | C | Note payable - related party | |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Weighted Average Ordinary Shares Outstanding Basic And Diluted12 | 0001829126-25-004454 | 1 | 0 | shares | D | Weighted average ordinary shares outstanding, basic and diluted | ||
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Deferred Offering Costs Paid By Related Party Under Promissory Note | 0001829126-25-004454 | 1 | 0 | monetary | D | C | Deferred offering costs paid by related party under promissory note | |
| General And Administrative Expenses Paid By Sponsor Under Promissory Note | 0001829126-25-004454 | 1 | 0 | monetary | D | D | General and administrative expenses paid by Sponsor under promissory note | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Deferred Offering Costs Included In Accounts Payable | 0001829126-25-004454 | 1 | 0 | monetary | D | C | Deferred offering costs included in accounts payable |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-004454 | 2 | 2 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001829126-25-004454 | 2 | 3 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001829126-25-004454 | 2 | 4 | BS | 0 | H | Deferred Offering Costs Associated With Proposed Public Offering | 0001829126-25-004454 | Deferred offering costs associated with proposed public offering | 0 |
| 0001829126-25-004454 | 2 | 5 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001829126-25-004454 | 2 | 6 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001829126-25-004454 | 2 | 7 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001829126-25-004454 | 2 | 8 | BS | 0 | H | Note Payable Related Party | 0001829126-25-004454 | Note payable - related party | 0 |
| 0001829126-25-004454 | 2 | 9 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001829126-25-004454 | 2 | 10 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001829126-25-004454 | 2 | 11 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | 0 |
| 0001829126-25-004454 | 2 | 12 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary shares, $0.0001 par value; 550,000,000 shares authorized; 7,503,750 shares issued and outstanding | 0 |
| 0001829126-25-004454 | 2 | 13 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001829126-25-004454 | 2 | 14 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001829126-25-004454 | 2 | 15 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders deficit | 0 |
| 0001829126-25-004454 | 2 | 16 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Shareholders Deficit | 0 |
| 0001829126-25-004454 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001829126-25-004454 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001829126-25-004454 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001829126-25-004454 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001829126-25-004454 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001829126-25-004454 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001829126-25-004454 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001829126-25-004454 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001829126-25-004454 | 4 | 1 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001829126-25-004454 | 4 | 2 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-004454 | 4 | 3 | IS | 0 | H | Weighted Average Ordinary Shares Outstanding Basic And Diluted12 | 0001829126-25-004454 | Weighted average ordinary shares outstanding, basic and diluted | 0 |
| 0001829126-25-004454 | 4 | 4 | IS | 0 | H | Basic And Diluted Net Loss Per Ordinary Share | 0001829126-25-004454 | Basic and diluted net loss per ordinary share | 0 |
| 0001829126-25-004454 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance - December 31, 2024 | 0 |
| 0001829126-25-004454 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0001829126-25-004454 | 5 | 10 | EQ | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-004454 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance - March 31, 2025 (unaudited) | 0 |
| 0001829126-25-004454 | 5 | 12 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0001829126-25-004454 | 6 | 1 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-004454 | 6 | 2 | CF | 0 | H | General And Administrative Expenses Paid By Sponsor Under Promissory Note | 0001829126-25-004454 | General and administrative expenses paid by Sponsor under promissory note | 0 |
| 0001829126-25-004454 | 6 | 3 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001829126-25-004454 | 6 | 4 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001829126-25-004454 | 6 | 5 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0001829126-25-004454 | 6 | 6 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - beginning of the period | 0 |
| 0001829126-25-004454 | 6 | 7 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - end of the period | 0 |
| 0001829126-25-004454 | 6 | 9 | CF | 0 | H | Deferred Offering Costs Included In Accounts Payable | 0001829126-25-004454 | Deferred offering costs included in accounts payable | 0 |
| 0001829126-25-004454 | 6 | 10 | CF | 0 | H | Deferred Offering Costs Paid By Related Party Under Promissory Note | 0001829126-25-004454 | Deferred offering costs paid by related party under promissory note | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |